Fused cyclic modulators of nuclear hormone receptor function
申请人:——
公开号:US20030114420A1
公开(公告)日:2003-06-19
Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.
[EN] HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE LA PROTEINE TYROSINE KINASE, A BASE D'IMIDAZOPYRAZINE A SUBSTITUTION HETEROCYCLO
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:WO1999045009A1
公开(公告)日:1999-09-10
(EN) Novel heterocyclo-substituted imidazopyrazines and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic disorders.(FR) L'invention concerne des imidazopyrazines à substitution hétérocyclo, et des sels de celles-ci, des compositions pharmaceutiques contenant de tels composés, ainsi que des procédés d'utilisation de ces composés dans le traitement de troubles associés à la protéine tyrosine kinase, tels que des troubles d'ordre immunologique.